Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

YEAR 4 CANCER CARE > Haem Malignancy: Myloproliferative Disorders And Myelodysplastic Disorders > Flashcards

Haem Malignancy: Myloproliferative Disorders And Myelodysplastic Disorders Flashcards

1
Q

What are myeloproliferative disorders?

A

Caused by clonal proliferation of haematopoietic myeloid stem cells in the bone marrow.

These cells can differentiate into RBCS, WBCS, or platelets, causing an excess of one or more of these cell types

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What types of myeloproliferative disorders do you get?

A
  • Primary myelofibrosis
  • Polycythaemia vera
  • Essential thrombocythaemia
    Dr Tom says above are 3 main
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Myeloproliferative disorders have the potential to progress and transform into ……?

What gene mutations are myeloproliferative disroders associated with?

A
  • Can progress and transform into acute myeloid leukaemia

Gene mutations:
* JAK2
* MPL
* CALR

TOM TIP: Remember the JAK2 mutation for your exams. This can be the target of JAK2 inhibitors such as ruxolitinib.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is polycythaemia vera?
what is it caused by?

A
  • myeloproliferative disorder characterised by the excess production of erythrocytes.
  • 98% of cases caused by a genetic mutation in the JAK2 gene
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Myeloproliferative disorders result in the excess production of myeloid cells: erythrocytes (red blood cells), platelets or granulocytes (neutrophils, eosinophils and basophils).

When excess red blood cells are produced resulting in a raised haemoglobin concentration and haematocrit this is called…?

A

polycythaemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Contrast primary and secondary polycythaemia

A

primary polycythaemia
* polycythameia vera - excess erythroyctes due to JAK 2 gene

Secondary polycythaemia
* physiological response to chronic hypoxia (i.e. smoking / chronic lung disease), renal e.g. renal artery stenoiss , or excess EPO (i.e. EPO secreting tumours)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

RF for polycythemia vera ?

A
  • Advancing age: median age at diagnosis is 60-70 years
  • History of Budd-Chiari syndrome: a proportion of people will have a JAK2 mutation even if they had initially normal blood counts
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

RF for polycythemia vera ?

A
  • Advancing age: median age at diagnosis is 60-70 years
  • History of Budd-Chiari syndrome: a proportion of people will have a JAK2 mutation even if they had initially normal blood counts
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

History of symptoms fro Polycythaemia vera?

A
  • Headaches: usually associated with dizziness and sweating
  • Myalgia and weakness
  • Fatigue
  • Tinnitus
  • Pruritis: particularly after a hot shower or bath
  • Erythromelalgia: burning pain, warmth and redness in the hands and feet
  • Blurred vision: temporary loss of vision due to hyper-viscosity
  • Dyspepsia: peptic ulceration
  • Gout: due to increased cell turnover
  • thrombosis (75% arterial) i.e presnt with STROKE, MI, DVT, PE, BUDD CHIARI sydnrome
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What might you see when clinically examinaing a pt with polycythaemia vera?

A
  • a ‘ruddy’ (reddish) / plethoric complexion
  • Splenomegaly
  • Abdominal masses: benign and malignant uterine, renal and hepatic tumours which can secrete EPO may be palpable
  • Hypertension
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Differencial diagnosis for polycythaemia vera? i.e. raised HB

A

Hypoxia driven:
* COPD
* smoking
* carbon monoxide poisoning
* sleep apnoea
* left to right cardiac shunts (Eisenmenger’s syndrome)
* high altitude

Local renal hypoxia:
* e.g.renal artery stenosis

Pathological EPO production:
* EPO secreting tumours; e.g. clear cell renal carcinoma, Wilms’ tumour, hepatocellular carcinoma, cerebellar haemangioblastoma, pheochromocytoma, uterine myoma, parathyroid carcinoma and meningioma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Investigations for polycythaemia vera: how is it defined in terms of lab resutls
dont think really need to know off by heart

A

Polycythaemia is defined as:

  • Haemoglobin (Hb) >185 g/L and/or haematocrit (Hct) > 0.52 in males
  • Hb >165 g/L and/or Hct > 0.48 in females
  • Red cell mass >25% above predicted
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

If a pt is dehydrated they may have apparent polycythaemia. The hb and haematocrit is riased.
why is it raised?
What can you look at to work if true polycythaemia?
What other lab results may be raised?

A
  • Hb / Hct is raised due to reduced plasma volume (dehydrated)
  • look at - red cell mass - will be normal
  • Neutrophilia and thrombocytosis often see in PV
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are other lab investigations for Polycythaemia vera? think about ruling stuff in / out

A

FBC:
* high: RCC, Hb, HCt, PCV, WBC, platelets

Blood film:
* assess for leukaemia - require BM assessment

U&E/LFTs:
* renal/hepatic causes ( tumours), complications (e.g. Budd-Chiari syndrome)?

Serum ferritin:
* normal or low - big demand for iron

Arterial blood gas:
* hypoxia? (smoking) raised carboxyhaemoglobin?

Serum EPO:
* suppressed levels - PV.
* raised levels -secondary cause; inappropriate EPO production and the possibility of an EPO-secreting tumour.

JAK 2 V617F mutational analysis:
* positive in 95% of patients with PV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Specialist investigations and imaging for poylcythaemia vera?

A

Bone marrow biopsy:
* to distinguish from secondary PV
* hypercellularity, erythroid hyperplasia

Imaging:
* Abdominal US - splenomegaly and exlcude secondary causes of PV i.e. renal and hepatic
* CT head/neck/chest/abdo/pelvis - rare EPO secreting tumours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How are pts with Polycythaemia managed?

A

Phlebotomy
* intemrittend and long term to keep haematocrit <0.45

Aspirin
* reduce thrombotic events and death

Cytoreductvie therapy
* hydroxycaramide - first line
* interferon-alfa - child bearing women as not teratogenic

17
Q

complications ofr Polycythaemia vera?

A

Ischaemic stroke
Myocardial infarction
Pulmonary embolism
Progression to myelofibrosis or acute myeloid leukaemia
Gastrointestinal haemorrhage
Budd-Chiari syndrome

18
Q

What is myelofibrosis?
what can it result in?

A
  • proliferation of the cell line leads to fibrosis of the bone marrow.
  • This is due to cytokines e.g. fibroblast growth factor released by cells.
  • leading to anaemia and leukopenia
  • the BM is full of scar tissue and so extramedullary haematopoiesis happens elsewehere e.g. liver and spleen.
  • leading to hepatomegaly and splenomegaly.
  • resulting in- portal HTN.
  • If it occurs around the spine- spinal cord compression.
19
Q

What is myelofibrosis caused by?

A
  • primary myelofibrosis
  • polycythaemia vera
  • essential thrombocythaemia.
20
Q

How might a patient with myelofibrosis present?

A
  • night sweats
  • fever
  • weight loss
  • abdominal discomfort (splenomegaly)
  • low Hb (BM failure)
  • infections (BM failure)
  • bleeding (BM failure)
21
Q

Investigations and results for myelofibrosis?

include the diagnostic test

A

FBC
* anaemia low Hb
* Leukocytosis OR leukopenia
* Thrombocytosis or Thrombocytopenia

Blood film
* Leukoerythroblastic cells, characteristic teardrop RBCS, varying sizes of red blood cells (poikilocytosis) and immature red and white cells (blasts).

Bone marrow trephine for diagnosis
* may be ‘dry’ as scar tissue

Genetic testing:
* JAK2, MPL and CALR genes can help guide management.

22
Q

How do you manage primary Myelofibrosis?

A

patient with mild disease and minimal symptoms:
* Watch and wait

Allogenic stem cell transplant
* can be curative but has risks

Chemotherapy
* contol disease, improve symptoms, slow progession
* not curative on its own

Supportive
* anameia, splenomegaly, portal HTN

23
Q

What is essential thrombocythaemia?
What can it cause?

A

A clonal proliferation of megakaryocytes leads to persistently high platelets, > 600 x 109/l) with abnormal function.

Can cause:
* bleeding
* arterial / venous thrombosis
* microvascular occlusions - headache
* atypical chest pain
* light headesness
* erythromelalgia

some sources say platelets > 1000 x 109

24
Q

What are some causes of thrombocytosis?

A
25
Q

This is result of BM biospsy- marrow trephine in myelofibrosis:

What are other causes of marrow fibrosis?

A
  • any myeloproliferative disorder
  • lymphoma
  • secondary carcinoma
  • TB
  • leukaemia
  • irradiation
26
Q

For interest slide - see images

A
27
Q

Treatment of essential thrombocythaemia?

A
  • aspirin 75 mg OD
  • hydroxycarbamide in high risk patients
28
Q

What signs and symptoms of underlying conditions might you see in any pts with myeloproliferative disorders ?

dr tom

A
  • Anaemia (except in polycythaemia)
  • Splenomegaly (abdominal pain)
  • Portal hypertension (ascites, varices and abdominal pain)
  • Low platelets (bleeding and petechiae)
  • Thrombosis is common in polycythaemia and thrombocythaemia
  • Raised red blood cells (thrombosis and red face)
  • Low white blood cells (infections)
29
Q

What is Myelodysplastic syndrome? what blood results may you see?

A
  • myeloid bone marrow cells do not mature properly
  • bone marrow failure
  • Many specific types of myelodysplastic syndrome.
  • low levels of blood components that originate from the myeloid cell line:
  • Anaemia
  • Neutropenia (low neutrophil count)
  • Thrombocytopenia (low platelets)
30
Q

Who gets Myelodysplastic syndrome?

A
  • patients > 60 years
  • patients who have previously had chemotherapy or radiotherapy.
31
Q

What is the risk of Myelodysplastic syndrome?

A

increased risk of transforming into acute myeloid leukaemia.

32
Q

How might a patient with myelodysplastic syndrome present?

A
  • asymptomatic - incidental FBC finding
  • anameic - fatigue, pallor, SOB
  • neutropenia - infections ( can be lifethreatening)
  • thrombocytpenia - purpura / bleeding
33
Q

Investigations for Myelodysplastic syndromes ?

how is diagnosis confirmed?

A

FBC
* pancytopenia
* macrocytic anaemia
* low reticulocyte count

Blood film:
* blasts present

Diagnosed with BM biopsy
* marrow cellularity due to ineffective haematopoiesis

34
Q

Treatment for myelodysplastic syndromes

A

Watch + wait

Transfusions
* red cells / platelets
* EPO

Allogenic stem cell transplant
* curative but risky

Chemotherapy -QOL if symptomatic

YEAR 4 CANCER CARE (22 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions